Tara-set tablet

Adult dose

For children over 12 years and adults: The dosage is adjusted according to the patient's level of pain and therapeutic response. It is recommended to start with a dose of 2 tablets, and thereafter, the dosing interval should be at least 6 hours, with no more than 8 tablets per day. The lowest effective dose should be used for as short a duration as possible. This medication should not be taken longer than necessary, and if long-term use is required due to disease characteristics and severity, regular monitoring should be conducted to confirm the continuation of this medication. Elderly The usual adult dosage should be administered. However, for elderly patients over 75 years, when tramadol is taken orally, the elimination half-life of tramadol increases by 17%, so administration should be at least 6 hours apart. Renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30 ml/min), the dosing interval should be extended to 12 hours. For patients with severe renal impairment (creatinine clearance less than 10 ml/min), administration is not recommended. Tramadol is removed very slowly by hemodialysis and filtration; therefore, there is no need to readminister this medication after dialysis to maintain analgesic effect. Hepatic impairment For patients with moderate hepatic impairment, careful consideration should be given to extending the dosing interval. This medication should not be administered to patients with severe hepatic impairment.

Child dose

Same as for children over 12 years of age and adults

This medicine may put a strain on the liver, so those who regularly consume more than three alcoholic drinks a day should consult a doctor or pharmacist before taking it. During the course of taking this medication, skin rashes or severe allergic reactions may occur, and if such symptoms appear, you must immediately stop taking it and consult a healthcare professional. The ingredients in this medication may cause seizures, so patients with a history of seizures or those at high risk of seizures should exercise special caution. Patients with severe respiratory diseases are at risk of respiratory suppression when taking this medication, so it should be administered under the supervision of a healthcare professional, and if possible, alternative analgesics should be used. This medication can affect the central nervous system, and taking it along with alcohol or other sedatives may cause severe drowsiness or respiratory suppression, so co-administration must be avoided. Patients with head injuries or elevated intracranial pressure should exercise caution when taking this medication as symptoms may worsen. This medication may lead to physical and psychological dependence, so strict management of dosage and duration according to a doctor's instructions is necessary during long-term use. Patients with poor liver function must consult with a healthcare professional before taking this medication, and they should not exceed the daily dosage to reduce the risk of liver damage. Patients with certain genetic metabolic characteristics may metabolize the active ingredients of this medication rapidly in their bodies, increasing the risk of respiratory suppression; in such cases, alternative medications or dosage adjustments may be necessary. This medication should not be administered to children under 12 years of age or to certain children post-surgery, and it should be avoided in adolescents aged 12 to under 18 with certain risk factors. Patients with sleep apnea or at risk of hypoxia should periodically check their symptoms while taking this medication and reduce or discontinue the dosage if necessary. This medication may cause hyponatremia, so elderly patients or those at risk of hyponatremia should monitor for symptoms during treatment. Patients allergic to any component of this medication or experiencing severe respiratory depression, head trauma, or receiving specific medications should not take it. During treatment, it is advisable to avoid driving or operating hazardous machinery, as drowsiness or dizziness may occur. In case of overdose, severe respiratory suppression, seizures, and liver damage may occur, so adherence to the dosage is critical, and if unusual symptoms arise, an immediate visit to a medical facility is required. This medication should be stored securely out of the reach of children, with precautions taken to prevent misuse and accidents.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary issues

Mild side effects

• Reduced appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

This medication should be stored in a sealed container to prevent exposure to air and moisture. The storage temperature should be maintained at room temperature below 25 degrees Celsius, and direct sunlight should be avoided.

Appearance

Light yellow, rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle